Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Hepatoprotective Potential of Green Synthesized Nanoparticles from Citrus reticulata Peel Extract against HFS Diet-Induced NASH in Mice, Integrated with Chemical Profiling and Molecular Modeling

- Elhady S.S. , et al.

2. Role of waist circumference, body mass index and high-sensitivity C-reactive protein in pediatric steatotic liver disease: A cross-sectional study

- Wu Q. , et al.

3. Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases

- Burra P. , et al.

4. Predictive markers of metabolically healthy obesity in children and adolescents: can AST/ALT ratio serve as a simple and reliable diagnostic indicator?

- Çelik N. , et al.

5. The association of tonsillar microbiota with biochemical indices based on obesity and tonsillar hypertrophy in children

- Park J. , et al.

6. Protective effects of Echinacea purpurea ethanol extract on male reproductive dysfunction in obese rats

- Kong Z.L. , et al.

7. Single nucleotide polymorphisms in PEMT and MTHFR genes are associated with omega 3 and 6 fatty acid levels in the red blood cells of children with obesity

- Serafim V. , et al.

8. Alanine aminotransferase as a marker for diagnosing metabolic syndrome and cardiovascular risk in obese children

- Cabrera Y. , et al.

9. A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE

- Zaman A. , et al.

10. The salivary levels of leptin and interleukin-6 as potential inflammatory markers in children obesity

- Pîrsean C. , et al.

11. IRX3 is a genetic modifier for birth weight, adolescent obesity and transaminase metabolism

- Liu C. , et al.

12. Associations between Liver Enzyme Levels and Parameters of the Metabolic Syndrome in Obese Children

- Hampe C.S. , et al.

13. A Novel Role of SIRT1/ FGF-21 in Taurine Protection Against Cafeteria Diet-Induced Steatohepatitis in Rats

- Abd Elwahab A.H. , et al.

14. Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children

- Kan X. , et al.

15. Acute fatty liver of pregnancy: A life-threatening condition requiring a life-saving approach

- Gorginzadeh M. , et al.

16. Paediatric non-alcoholic fatty liver disease: A practical overview for non-specialists

- Mann J.P. , et al.

17. Non-alcoholic fatty liver and metabolic syndrome in children: A vicious circle

- Alterio A. , et al.

18. Dietary blueberry and bifidobacteria attenuate nonalcoholic fatty liver disease in rats by affecting SIRT1-mediated signaling pathway

- Ren T. , et al.

19. Screening for elevated risk of liver disease in preschool children (Aged 2–5 years) being seen for obesity management

- Beacher D.R. , et al.